Details for New Drug Application (NDA): 012071
✉ Email this page to a colleague
NDA 012071 describes DECADRON, which is a drug marketed by Merck and is included in eight NDAs. Additional details are available on the DECADRON profile page.
The generic ingredient in DECADRON is dexamethasone acetate. There are four drug master file entries for this compound. Additional details are available on the dexamethasone acetate profile page.
The generic ingredient in DECADRON is dexamethasone acetate. There are four drug master file entries for this compound. Additional details are available on the dexamethasone acetate profile page.
Summary for 012071
| Tradename: | DECADRON |
| Applicant: | Merck |
| Ingredient: | dexamethasone sodium phosphate |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 4MG PHOSPHATE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 24MG PHOSPHATE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
